The board of directors Amgen (NASDAQ:AMGN) approved a dividend of USD1.45 per share of the company's stock for the first quarter of 2019, it declared on Friday
This dividend is payable on 8 March 2019 to all stockholders of record at the close of business as of 15 February 2019.
Amgen added that the new dividend marks a growth of 10% from each of the previous four quarters.
Since 1980, the company said it has focused on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and has reached millions of patients around the world.
Bruker Corporation to acquire ELITechGroup for EUR870m, strengthening MDx portfolio
Perrigo announces quarterly dividend increase
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva
Biosenic finalises agreement with Phebra for oral arsenic troxide development